Corruption charges against GlaxoSmithKline Plc (GSK.L) executives in China are a warning to other foreign firms and could do irreparable damage to the British drugmaker’s Chinese operations, the official Xinhua news agency said on Friday.
Chinese police charged GSK’s former China boss, Briton Mark Reilly, and two other colleagues with corruption on Wednesday after a 10-month probe found the firm made billions of yuan from bribing doctors and hospitals.
Healthcare is a highly sensitive area in China and has become a focal point for President Xi Jinping’s attack on corporate graft, with a number of global and Chinese drugmakers coming under the spotlight for corruption.
Read Full Article HERE
Adam Jourdan, Reuters via CHINA US Focus http://ift.tt/1jCENCo
No comments:
Post a Comment